The independent source for health policy research, polling, and news.
One of Montana’s largest safety-net health centers announced it will lay off nearly 10% of its workforce because of revenue losses it attributes to vast Medicaid disenrollments. Such cuts are happening elsewhere too.
Ballad Health, a 20-hospital system in Tennessee and Virginia, benefits from the largest state-sanctioned hospital monopoly in the United States and is the only option for hospital care for a large swath of Appalachia.
Federal officials are offering $75 to dairy workers who agree to be tested for bird flu. Advocates say the payments aren’t enough to protect workers from lost wages and health care costs if they test positive.
Mounting evidence suggests psychoactive drugs including LSD, ketamine, mushrooms, and MDMA can be powerful treatments for severe depression and PTSD. But not everyone is convinced. And even if such drugs gain FDA approval, safety protocols could render them extremely expensive.
A sedative shouldn’t be the first thing tried to help people with dementia who exhibit distressing behaviors. A new website is a comprehensive, free resource that offers guidance to caregivers.
A Florida law was enacted this spring making the Sunshine State the first in the nation to let cesarean sections be performed in settings other than hospitals — leading to warnings about increased risks for pregnant women and their babies.
ºÚÁϳԹÏÍø News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Federal regulations prevent gay and bisexual men from donating tissue, such as corneas, ligaments, and blood vessels. Similar restrictions have been relaxed or lifted for donated blood and organs in recent years.
A single Central Florida county reported 13% of all U.S. leprosy cases in 2020. Researchers have teamed up to investigate whether armadillos are passing the bacteria that cause the disease to humans — which is especially concerning as the animals expand their range farther north.
While Republican candidates in many states downplay their opposition to abortion, the most vehement wing of the movement, which helped overturn Roe v. Wade — those who advocate prosecuting patients, outlawing contraception, and banning IVF — are increasingly outspoken. Meanwhile, some state legislatures continue to advance new restrictions, like a proposal moving in Louisiana to include abortion medications mifepristone and misoprostol on the list of the most dangerous drugs. Alice Miranda Ollstein of Politico, Rachel Roubein of The Washington Post, and Joanne Kenen of the Johns Hopkins schools of public health and nursing and Politico Magazine join ºÚÁϳԹÏÍø News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Shefali Luthra of The 19th about her new book on abortion in post-Roe America, “Undue Burden.â€
Dairy farmers and veterinarians in northern Texas furiously investigated a mysterious illness among cattle before the government got involved. Their observations are telling.
Los Angeles County, the nation’s most populous county, is spearheading a comprehensive plan to tackle a $2.9 billion medical debt crisis. Hospitals are still getting on board with the project, which is helmed by the public health department.
Vaccine scare tactics haven’t shifted, but more parents are falling for them. Here’s what the rhetoric gets wrong and how it endangers children.
California’s Medicaid program is testing a novel approach for people addicted to methamphetamine, cocaine, and other stimulants. For every clean urine test, they can earn money — up to $599 a year.
A man from Michigan was evacuated from a cruise ship after having seizures. First, he drained his bank account to pay his medical bills.
With tens of thousands of Americans already affected by enrollment scams that leave some without doctors or treatments, Oregon Sen. Ron Wyden wants increased enforcement against rogue agents or other perpetrators and legislation to allow for criminal penalties.
The makers of Ozempic and Mounjaro charge list prices of around $1,000 a month for the diabetes and obesity drugs, and insurers are reluctant to pick up the tab. Often, low-income patients have to resort to less effective treatments.
